New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Abstract Proteolysis-targeting chimeras (PROTACs) technology has garnered significant attention over the last 10 years, representing a burgeoning therapeutic approach with the potential to address pathogenic proteins that have historically posed challenges for traditional small-molecule inhibitors....
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-05-01
|
| Colección: | Molecular Cancer |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12943-024-02024-9 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|